Fuse Biotherapeutics logo

Fuse Biotherapeutics Funding & Investors

Los Angeles, CA

Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent responses to danger are targeted without sacrificing natural breaks in the system that spare healthy tissues. Fuse Biotherapeutics was founded in 2021 and is headquartered in Los Angeles, CA.

fusebiotx.com

Total Amount Raised: $9,500,000

Fuse Biotherapeutics Funding Rounds

  • Seed

    $9,500,000

    Seed Investors

    Viva Biotech Shanghai
    Ivy Venture Group
    GC&H Investments
    Sirona Capital
    Sherpa Healthcare Partners (夏尔巴投资)
Funding info provided by Diffbot.